A clinical trial is currently underway to determine if the popular weight-loss drug, Zepbound, could also be effective in treating obstructive sleep apnea. If successful, Zepbound may become covered by Medicare in the future, similar to how Wegovy will be covered due to its clinical benefits in treating diseases beyond just obesity. With nearly 30 million Americans suffering from obstructive sleep apnea, but only 6 million diagnosed, raising awareness about the condition is crucial.
Obstructive sleep apnea occurs when breathing is interrupted during sleep due to relaxed muscles around the throat, causing the airway to block. Risk factors for developing the disease include being overweight or obese, having a large or thick neck, having chronic nasal congestion, smoking, and anatomic abnormalities that block the airway. While some patients may have no symptoms, most individuals with the condition may experience snoring, unrestful sleep, morning headaches, depression, and daytime sleepiness.
Diagnosing obstructive sleep apnea typically involves visiting a doctor for a detailed history, physical exam, and possibly a sleep study. Treatments for the condition aim to improve sleep quality and resolve breathing disruptions, with options including continuous positive airway pressure machines, oral appliances, surgery, and behavioral changes like weight loss and side-sleeping. The condition not only disrupts sleep but can also have profound effects on overall health, including fatigue, irritability, difficulty concentrating, impaired cognitive function, and an increased risk of cardiovascular disease.
Many Americans with obstructive sleep apnea may dismiss their symptoms as normal aging or may not even be aware they have the condition. Raising awareness about this critical public health issue is essential in helping individuals understand, treat, and cope with the disease. Given the significant impact obstructive sleep apnea can have on health and well-being, it is important for individuals to seek diagnosis and appropriate treatment to improve their quality of life and reduce the risk of associated health complications.
